Search research articles
Contact Us
Filters
Showing results (711-720 of 754) with videos related to
Page
of 76
Sort By:
European Journal of Heart Failure
|
December 15, 2024
Effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum in PARAGON-HF
Xiaowen Wang, Orly Vardeny, Brian Claggett, et al.
European Journal of Heart Failure
|
August 26, 2020
Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF
Senthil Selvaraj, Brian L Claggett, Marc A Pfeffer, et al.
JACC. Heart Failure
|
June 10, 2025
Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction: A Participant-Level Pooled Analysis of 4 Contemporary Trials
Mats C H Lassen, John W Ostrominski, Brian L Claggett, et al.
Circulation. Heart Failure
|
June 23, 2023
Predicting Stroke in Heart Failure and Preserved Ejection Fraction Without Atrial Fibrillation
Toru Kondo, Karola S Jering, Pardeep S Jhund, et al.
JACC. Heart Failure
|
April 4, 2020
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction
Jonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
BMC Medicine
|
November 11, 2016
Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives
João Pedro Ferreira, Nicolas Girerd, Pierpaolo Pellicori, et al.
Frontiers in Digital Health
|
November 7, 2022
Considerations in the reliability and fairness audits of predictive models for advance care planning
Jonathan Lu, Amelia Sattler, Samantha Wang, et al.
JACC. Heart Failure
|
July 1, 2017
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial
Scott D Solomon, Adel R Rizkala, Jianjian Gong, et al.
The New England Journal of Medicine
|
April 1, 2014
Survival with cardiac-resynchronization therapy in mild heart failure
Ilan Goldenberg, Valentina Kutyifa, Helmut U Klein, et al.
The New England Journal of Medicine
|
April 11, 2014
Spironolactone for heart failure with preserved ejection fraction
Bertram Pitt, Marc A Pfeffer, Susan F Assmann, et al.
Page
of 76
Search research articles
Search
Showing results (711-720 of 754) with videos related to
Sort By:
Page
of 76
European Journal of Heart Failure
|
December 15, 2024
Effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum in PARAGON-HF
Xiaowen Wang, Orly Vardeny, Brian Claggett, et al.
European Journal of Heart Failure
|
August 26, 2020
Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF
Senthil Selvaraj, Brian L Claggett, Marc A Pfeffer, et al.
JACC. Heart Failure
|
June 10, 2025
Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction: A Participant-Level Pooled Analysis of 4 Contemporary Trials
Mats C H Lassen, John W Ostrominski, Brian L Claggett, et al.
Circulation. Heart Failure
|
June 23, 2023
Predicting Stroke in Heart Failure and Preserved Ejection Fraction Without Atrial Fibrillation
Toru Kondo, Karola S Jering, Pardeep S Jhund, et al.
JACC. Heart Failure
|
April 4, 2020
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction
Jonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
BMC Medicine
|
November 11, 2016
Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives
João Pedro Ferreira, Nicolas Girerd, Pierpaolo Pellicori, et al.
Frontiers in Digital Health
|
November 7, 2022
Considerations in the reliability and fairness audits of predictive models for advance care planning
Jonathan Lu, Amelia Sattler, Samantha Wang, et al.
JACC. Heart Failure
|
July 1, 2017
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial
Scott D Solomon, Adel R Rizkala, Jianjian Gong, et al.
The New England Journal of Medicine
|
April 1, 2014
Survival with cardiac-resynchronization therapy in mild heart failure
Ilan Goldenberg, Valentina Kutyifa, Helmut U Klein, et al.
The New England Journal of Medicine
|
April 11, 2014
Spironolactone for heart failure with preserved ejection fraction
Bertram Pitt, Marc A Pfeffer, Susan F Assmann, et al.
Page
of 76